Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

151.73 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
From Charles River Laboratories International, Inc.
Via Business Wire
3 Healthcare Stocks With Huge Growth Potential
It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead. 
Via InvestorPlace
Bragar Eagel & Squire, P.C. Is Investigating Fox, Charles River, Provident, and Sarepta and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Will Chart Analysts Notice Bad Omen on Charles River's Chart
Via Benzinga
Analyst Ratings for Charles River
Via Benzinga
Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories Showcases End-to-End Oncology Capabilities at AACR 2023
From Charles River Laboratories International, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Fox, FTX, RH, and Charles River and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Supply Chain
Charles River Laboratories International, Inc. (NYSE:CRL) Investor Alert: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 03/13/2023 -- An investigation was announced for investors of Charles River Laboratories International, Inc. (NYSE:CRL) shares over potential securities laws violations by... 
Via SBWire
Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories to Present at Barclays Global Healthcare Conference
From Charles River Laboratories International, Inc.
Via Business Wire
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Supply Chain
Charles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing
From Charles River Laboratories International, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Fox, Norfolk Southern, Charles River, and CCSI and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Supply Chain
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Supply Chain
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
$39M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed lower on Friday, there were a few notable insider trades. 
Via Benzinga
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses to Inquire About Securities Class Action Investigation - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Supply Chain
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Charles River Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
CRL EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors With Losses In Excess of $100K to Inquire About Securities Class Action Investigation – CRL
From The Rosen Law Firm, P.A.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Charles River Laboratories International, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Charles River Laboratories International, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.